Earum Pharmaceuticals Ltd - 542724 - Unaudited Financial Results For Quarter And Half Year Ended On September 30,2021
Unaudited financial results for quarter and half year ended on September 30,202130-10-2021
30-10-2021
Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held On October 30,2021
Considered and approved Unaudited financial results for the quarter and half year ended on September 30,202130-10-2021
Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting
Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2021 ,inter alia, to consider and approve Intimation of Board Meeting to be held on October 30,202121-10-2021
Earum Pharmaceuticals Ltd - 542724 - Shareholding for the Period Ended September 30, 2021
Earum Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here16-10-2021
Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate Under Regulation 74(5) Of SEBI (Depositories And Participants) Regulations, 2018 for quarter ended on September 30, 202116-10-2021
Earum Pharmaceuticals Ltd - 542724 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot08-10-2021
Earum Pharmaceuticals Ltd - 542724 - Corporate Action-Outcome of Sub division / Stock Split
Board approves split of shares of the Company08-10-2021
Earum Pharmaceuticals Ltd - 542724 - Board Meeting Outcome for Outcome Of Board Meeting Held On October 08,2021
Outcome of Board Meeting held on October 08,202108-10-2021
Earum Pharmaceuticals Ltd - 542724 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- PRIYA RAVALDesignation :- Company Secretary and Compliance Officer01-10-2021